NO20034695D0 - Nye sammensetninger - Google Patents

Nye sammensetninger

Info

Publication number: NO20034695D0
Authority: NO; Norway
Prior art keywords: new compositions; compositions; new
Prior art date: 2001-04-27

Application number

NO20034695A

Other languages

English (en)

Other versions

NO20034695L (no

Inventor

Serge Debrus

Louise Nathalie Mathy

Gerald Voss

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-27

Filing date

2003-10-20

Publication date

2003-10-20

2003-10-20 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2003-10-20 Publication of NO20034695D0 publication Critical patent/NO20034695D0/no

2003-12-03 Publication of NO20034695L publication Critical patent/NO20034695L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

NO20034695A 2001-04-27 2003-10-20 Nytt preparat NO20034695L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0110431A GB0110431D0 (en)	2001-04-27	2001-04-27	Novel compounds
PCT/EP2002/004966 WO2002087614A2 (en)	2001-04-27	2002-04-25	Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen

Publications (2)

Publication Number	Publication Date
NO20034695D0 true NO20034695D0 (no)	2003-10-20
NO20034695L NO20034695L (no)	2003-12-03

Family

ID=9913641

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034695A NO20034695L (no)	2001-04-27	2003-10-20	Nytt preparat

Country Status (20)

Country	Link
US (1)	US20040131638A1 (no)
EP (1)	EP1381390A2 (no)
JP (1)	JP2004531540A (no)
KR (1)	KR20040030599A (no)
CN (1)	CN1522153A (no)
AR (1)	AR034312A1 (no)
AU (1)	AU2002310802B2 (no)
BR (1)	BR0209161A (no)
CA (1)	CA2445310A1 (no)
CZ (1)	CZ20032942A3 (no)
GB (1)	GB0110431D0 (no)
HU (1)	HUP0303942A3 (no)
IL (1)	IL158428A0 (no)
MX (1)	MXPA03009698A (no)
MY (1)	MY134041A (no)
NO (1)	NO20034695L (no)
NZ (1)	NZ529039A (no)
PL (1)	PL367134A1 (no)
WO (1)	WO2002087614A2 (no)
ZA (1)	ZA200308188B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE357252T1 (de)	1998-10-16	2007-04-15	Glaxosmithkline Biolog Sa	Adjuvanzsysteme und impfstoffe
GB0206360D0 (en) *	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
US9045727B2 (en)	2002-05-17	2015-06-02	Emory University	Virus-like particles, methods of preparation, and immunogenic compositions
GB0225788D0 (en) *	2002-11-05	2002-12-11	Glaxo Group Ltd	Vaccine
GB0225786D0 (en) *	2002-11-05	2002-12-11	Glaxo Group Ltd	Vaccine
GB0405480D0 (en) *	2004-03-11	2004-04-21	Istituto Superiore Di Sanito	Novel tat complexes,and vaccines comprising them
GB0413510D0 (en) *	2004-06-16	2004-07-21	Glaxosmithkline Biolog Sa	Vaccine
SG153837A1 (en) *	2004-06-16	2009-07-29	Glaxosmithkline Biolog Sa	Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
US8778351B2 (en) *	2006-08-30	2014-07-15	University Of Rochester	Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
US8865185B2 (en)	2006-09-08	2014-10-21	The Trustees Of The University Of Pennsylvania	Methods of use for HSV-1 and HSV-2 vaccines
EP2059255A4 (en)	2006-09-08	2011-08-31	Univ Pennsylvania	VACCINES AGAINST HSV-1 AND HSV-2 AND METHODS OF USE
AU2007342345B9 (en) *	2006-12-28	2013-09-12	The Trustees Of The University Of Pennsylvania	Herpes Simplex Virus combined subunit vaccines and methods of use thereof
US10478490B2 (en)	2006-12-28	2019-11-19	The Trustees Of The University Of Pennsylvania	Herpes simplex virus combined subunit vaccines and methods of use thereof
US8057804B2 (en)	2006-12-28	2011-11-15	The Trustees Of The University Of Pennsylvania	Herpes simplex virus combined subunit vaccines and methods of use thereof
AR071910A1 (es) *	2008-05-26	2010-07-21	Cadila Healthcare Ltd	Vacuna combinada para el papiloma humano y el sarampion. vector. huesped.
MX2011006903A (es) *	2008-12-25	2011-09-15	Chemo Sero Therapeut Res Inst	Vacuna recombinante de coriza infecciosa aviar y procedimiento para preparar la misma.
EP2746394A4 (en) *	2011-08-19	2015-07-15	Ostrich Pharma Kk	ANTIBODY AND COMPOSITION CONTAINING THE SAME
AU2015335652B2 (en) *	2014-10-24	2020-07-02	Hpvvax, Llc.	Cancer and skin lesion treatment
BR112018067550A2 (pt) *	2016-02-27	2019-10-01	Hpvvax Llc	métodos para tratar um paciente que tem câncer de pele, tumor benigno ou canceroso ou uma lesão associada a papilomavírus humano (hpv), e composição farmacêutica
AU2017389221B2 (en) *	2016-12-26	2020-10-08	Access To Advanced Health Institute	Herpes zoster vaccine composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9620795D0 (en) *	1996-10-05	1996-11-20	Smithkline Beecham Plc	Vaccines
GB9720585D0 (en) *	1997-09-26	1997-11-26	Smithkline Beecham Biolog	Vaccine
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
DE60043708D1 (de) *	1999-10-13	2010-03-04	Novartis Vaccines & Diagnostic	Verfahren zur erhaltung zellimmuneantworten gegen proteinen

2001
- 2001-04-27 GB GB0110431A patent/GB0110431D0/en not_active Ceased
2002
- 2002-04-25 MX MXPA03009698A patent/MXPA03009698A/es unknown
- 2002-04-25 AU AU2002310802A patent/AU2002310802B2/en not_active Ceased
- 2002-04-25 HU HU0303942A patent/HUP0303942A3/hu unknown
- 2002-04-25 EP EP20020735335 patent/EP1381390A2/en not_active Withdrawn
- 2002-04-25 CZ CZ20032942A patent/CZ20032942A3/cs unknown
- 2002-04-25 IL IL15842802A patent/IL158428A0/xx unknown
- 2002-04-25 NZ NZ529039A patent/NZ529039A/en unknown
- 2002-04-25 CA CA002445310A patent/CA2445310A1/en not_active Abandoned
- 2002-04-25 WO PCT/EP2002/004966 patent/WO2002087614A2/en not_active Application Discontinuation
- 2002-04-25 BR BR0209161A patent/BR0209161A/pt not_active IP Right Cessation
- 2002-04-25 US US10/475,784 patent/US20040131638A1/en not_active Abandoned
- 2002-04-25 PL PL36713402A patent/PL367134A1/xx unknown
- 2002-04-25 KR KR10-2003-7014037A patent/KR20040030599A/ko not_active Application Discontinuation
- 2002-04-25 CN CNA028130480A patent/CN1522153A/zh active Pending
- 2002-04-25 AR ARP020101499A patent/AR034312A1/es not_active Withdrawn
- 2002-04-25 JP JP2002584958A patent/JP2004531540A/ja active Pending
- 2002-04-26 MY MYPI20021536A patent/MY134041A/en unknown
2003
- 2003-10-20 NO NO20034695A patent/NO20034695L/no not_active Application Discontinuation
- 2003-10-21 ZA ZA200308188A patent/ZA200308188B/en unknown

Also Published As

Publication number	Publication date
CN1522153A (zh)	2004-08-18
WO2002087614A2 (en)	2002-11-07
MXPA03009698A (es)	2004-01-29
NO20034695L (no)	2003-12-03
HUP0303942A3 (en)	2005-11-28
HUP0303942A2 (hu)	2004-03-01
PL367134A1 (en)	2005-02-21
ZA200308188B (en)	2005-01-21
EP1381390A2 (en)	2004-01-21
KR20040030599A (ko)	2004-04-09
BR0209161A (pt)	2004-08-03
AU2002310802B2 (en)	2005-03-24
WO2002087614A3 (en)	2003-04-24
MY134041A (en)	2007-11-30
CZ20032942A3 (cs)	2004-12-15
IL158428A0 (en)	2004-05-12
GB0110431D0 (en)	2001-06-20
CA2445310A1 (en)	2002-11-07
NZ529039A (en)	2005-02-25
US20040131638A1 (en)	2004-07-08
JP2004531540A (ja)	2004-10-14
AR034312A1 (es)	2004-02-18

Legal Events

Date	Code	Title	Description
2007-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20035428D0 (no)	2003-12-05	Nye anti-ineffektiver
NO20034992D0 (no)	2003-11-10	Nye 4-aninlinokinolin-3-karboksamider
NO20040014L (no)	2004-03-02	Nye forbindelser
NO20041003L (no)	2004-06-04	Nye forbindelser
NO20034665L (no)	2003-12-10	Nye forbindelser
FI20010780A0 (fi)	2001-04-12	Parannetut koostumukset
NO20033715L (no)	2002-04-30	Nye sammensetninger
DE60227853D1 (de)	2008-09-04	Substituierte Pyridinylamine
NO20034308D0 (no)	2003-09-26	Nye tyrokinase-inhibitorer
ITMI20011062A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
IS6915A (is)	2003-08-15	Lyfjablanda
NO20034970D0 (no)	2003-11-07	Nye arylheteroalkylaminderivater
BR0210619A (pt)	2006-05-23	composição
NO20034695D0 (no)	2003-10-20	Nye sammensetninger
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
ITMI20011061A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
IS7081A (is)	2003-12-16	Lyfjablanda
ITMI20011060A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
NO20015074L (no)	2001-11-15	Nye sammensetninger
ITMI20011059A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
NO20041185L (no)	2004-03-19	Nye sykloheksylsulfoner
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE50213651D1 (de)	2009-08-13	Substituierte 4-aminocyclohexanole
NO20035248D0 (no)	2003-11-26	Nye fenylalkyloksy-fenyl derivater
NO20025902D0 (no)	2002-12-09	Nye fenylpiperaziner